During the past decade, Ospedale Civile SS. Giovanni e Paolo conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile SS. Giovanni e Paolo" #1 sponsor was "Associazione Angela Serra per la ricerca sul cancro" with 1 trials, followed by "Associazione Volontari Pazienti Oncologici" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored and "Fatebenefratelli and Ophthalmic Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile SS. Giovanni e Paolo" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator, "Biotronik Italia" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP" with 1 trials as a collaborator and "Niguarda Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile SS. Giovanni e Paolo" are "Head and Neck Squamous Cell Carcinoma" (1 trials), "Hemosiderosis" (1 trials), "Implantable Cardioverter Defibrillator" (1 trials), "Lymphoma, T-Cell, Peripheral" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Ospedale Civile SS. Giovanni e Paolo" in a lesser frequency.

Most popular intervention types in "Ospedale Civile SS. Giovanni e Paolo" are "Drug" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferasirox" (1 trials), "Docetaxel" (1 trials), "Erlotinib" (1 trials), "INDUCTION CTx(TPF)+(RT+CDDP/5-FU)" (1 trials) and "INDUCTION CTx(TPF)+(RT+CETUXIMAB)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile SS. Giovanni e Paolo" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile SS. Giovanni e Paolo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale Civile SS. Giovanni e Paolo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile SS. Giovanni e Paolo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".